Discovery of a Natural Product-Like iNOS Inhibitor by Molecular Docking with Potential Neuroprotective Effects In Vivo
Open Access
- 1 April 2014
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 9 (4) , e92905
Abstract
In this study, we applied structure-based virtual screening techniques to identify natural product or natural product-like inhibitors of iNOS. The iNOS inhibitory activity of the hit compounds was characterized using cellular assays and an in vivo zebrafish larvae model. The natural product-like compound 1 inhibited NO production in LPS-stimulated Raw264.7 macrophages, without exerting cytotoxic effects on the cells. Significantly, compound 1 was able to reverse MPTP-induced locomotion deficiency and neurotoxicity in an in vivo zebrafish larval model. Hence, compound 1 could be considered as a scaffold for the further development of iNOS inhibitors for potential anti-inflammatory or anti-neurodegenerative applications.Keywords
This publication has 49 references indexed in Scilit:
- The holistic integration of virtual screening in drug discoveryDrug Discovery Today, 2013
- The discovery of novel, potent and highly selective inhibitors of inducible nitric oxide synthase (iNOS)Bioorganic & Medicinal Chemistry Letters, 2011
- Quercetin exerts a neuroprotective effect through inhibition of the iNOS/NO system and pro-inflammation gene expression in PC12 cells and in zebrafishInternational Journal of Molecular Medicine, 2011
- Structure‐Based Discovery of Natural‐Product‐like TNF‐α InhibitorsAngewandte Chemie International Edition, 2010
- Regulation of nitric oxide production in health and diseaseCurrent Opinion in Clinical Nutrition and Metabolic Care, 2010
- Drug Discovery and Natural Products: End of an Era or an Endless Frontier?Science, 2009
- Design, Synthesis, and Activity of 2-Imidazol-1-ylpyrimidine Derived Inducible Nitric Oxide Synthase Dimerization InhibitorsJournal of Medicinal Chemistry, 2007
- Nitric Oxide and Peroxynitrite in Health and DiseasePhysiological Reviews, 2007
- iNOS-mediated nitric oxide production and its regulationLife Sciences, 2004
- A selective inhibitor of inducible nitric oxide synthase inhibits exhaled breath nitric oxide in healthy volunteers and asthmaticsThe FASEB Journal, 2003